Cancer Statistics, 2017

CA Cancer Journal for Clinicians

Volumn 67, Issue 1, 2017, Pages 7-30

  Siegel, Rebecca L ^a   Miller, Kimberly D ^a   Jemal, Ahmedin ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

cancer cases; cancer statistics; death rates; incidence; mortality

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOID LEUKEMIA; ADOLESCENT; ADULT; AFRICAN AMERICAN; AMERICAN; ANUS CANCER; ARTICLE; ASIAN; BILE DUCT CANCER; BLADDER CANCER; BONE CANCER; BRAIN CANCER; BREAST CANCER; BRONCHUS CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER STATISTICS; CANCER SURVIVAL; CAUCASIAN; CHILD; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COLON CANCER; ESOPHAGUS CANCER; EYE CANCER; FEMALE; GALLBLADDER CANCER; HISPANIC; HUMAN; JOINT CANCER; KIDNEY CANCER; KIDNEY PELVIS TUMOR; LARYNX CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOUTH CANCER; MYELOMA; ORBIT CANCER; OVARY CANCER; PACIFIC ISLANDER; PANCREAS CANCER; PHARYNX CANCER; PROSTATE CANCER; RECTUM CANCER; SEX DIFFERENCE; SMALL INTESTINE CANCER; SOCIAL STATUS; SOFT TISSUE CANCER; STOMACH CANCER; SURVIVAL RATE; TESTIS CANCER; THYROID CANCER; TONGUE CANCER; UNITED STATES; URETER CANCER; UTERINE CERVIX CANCER; UTERUS CANCER; VAGINA CANCER; VULVA CANCER; ANCESTRY GROUP; CANCER REGISTRY; INCIDENCE; MORTALITY; NEOPLASMS; NON PROFIT ORGANIZATION; REGISTER; SEX RATIO; STATISTICS AND NUMERICAL DATA;

AMERICAN CANCER SOCIETY; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASMS; REGISTRIES; SEER PROGRAM; SEX DISTRIBUTION; SURVIVAL RATE; UNITED STATES;

EID: 85008220577     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.21387     Document Type: Article

References (70)

1. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Mortality-All COD, Total US (1969-2014) -Linked To County Attributes-Total US, 1969-2014 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2016; underlying mortality data provided by National Center for Health Statistics 2016.
2. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Mortality-All COD, Total US (1990-2014) -Linked To County Attributes-Total US, 1969-2014 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2016; underlying mortality data provided by National Center for Health Statistics 2016.
3. Wingo PA, Cardinez CJ, Landis SH, et al. Long-term trends in cancer mortality in the United States, 1930-1998. Cancer. 2003;97(suppl 12):3133-3275.
4. Murphy SL, Kochanek KD, Xu J, Heron M. Deaths: Final Data for 2012. National Vital Statistics Reports. Vol 63. No. 9. Hyattsville, MD: National Center for Health Statistics; 2015.
5. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 9 Regs Research Data, Nov. 2015 Sub (1973-2013) -Linked To County Attributes-Total US, 1969-2014 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2016.
6. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 9 Regs Research Data with Delay-Adjustment, Malignant Only, Nov. 2015 Sub (1975-2013) -Linked To County Attributes-Total US, 1969-2014 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2016.
7. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov. 2015 Sub (2000-2013) -Linked To County Attributes-Total US, 1969-2014 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2016.
8. Statistical Research and Applications Branch. DevCan: Probability of Developing or Dying of Cancer Software. Version 6.7.4. Bethesda, MD: Surveillance Research Program, Statistical Methodology and Applications, National Cancer Institute; 2012.
9. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2013. Bethesda, MD: National Cancer Institute; 2016.
10. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence Data-CiNA Analytic File, 1995-2013, for Expanded Races, Custom File With County, ACS Facts and Figures Projection Project (Which Includes Data From CDC's National Program of Cancer Registries [NPCR], CCCR's Provincial and Territorial Registries, and the NCI's Surveillance, Epidemiology and End Results [SEER] Registries). Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2016.
11. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence Data-CiNA Analytic File, 1995-2013, for NHIAv2 Origin, Custom File With County, ACS Facts and Figures Projection Project (Which Includes Data From CDC's National Program of Cancer Registries [NPCR], CCCR's Provincial and Territorial Registries, and the NCI's Surveillance, Epidemiology and End Results [SEER] Registries). Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2016.
12. Copeland G, Lake A, Firth R, et al. Cancer in North America: 2009-2013. Vol 1. Combined Cancer Incidence for the United States, Canada and North America. Springfield, IL: North American Association of Central Cancer Registries Inc; 2016.
13. Copeland G, Lake A, Firth R, et al. Cancer in North America: 2009-2013. Vol 2. Registry-Specific Cancer Incidence in the United States and Canada. Springfield, IL: North American Association of Central Cancer Registries Inc; 2016.
14. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, Third Edition. Cancer. 2005;103:1457–1467.
15. Fritz A, Percy C, Jack A, et al. International Classification of Diseases for Oncology. 3rd ed. Geneva: World Health Organization; 2000.
16. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th Rev. Vols I-III. Geneva: World Health Organization; 2011.
17. Surveillance Research Program, National Cancer Institute. SEER*Stat Software. Version 8.3.2. Bethesda, MD: Surveillance Research Program, National Cancer Institute; 2016.
18. Joinpoint Regression Program, Version 4.3.1.0. Bethesda, MD: Statistical Research and Applications Branch, National Cancer Institute; 2016.
19. Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst. 2002;94:1537-1545.
20. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 18 Regs Research Data with Delay-Adjustment, Malignant Only, Nov. 2015 Sub (2000-2013) -Linked To County Attributes-Total US, 1969-2014 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2016.
21. Pickle LW, Hao Y, Jemal A, et al. A new method of estimating United States and state-level cancer incidence counts for the current calendar year. CA Cancer J Clin. 2007;57:30-42.
22. Zhu L, Pickle LW, Ghosh K, et al. Predicting US- and state-level cancer counts for the current calendar year: Part II: evaluation of spatiotemporal projection methods for incidence. Cancer. 2012;118:1100-1109.
23. Chen HS, Portier K, Ghosh K, et al. Predicting US- and state-level cancer counts for the current calendar year: Part I: evaluation of temporal projection methods for mortality. Cancer. 2012;118:1091-1099.
24. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 1995;273:548-552.
25. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7-30.
26. Moyer VA; US Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157:120-134.
27. Harris JE. Cigarette smoking among successive birth cohorts of men and women in the United States during 1900-80. J Natl Cancer Inst. 1983;71:473-479.
28. Jemal A, Ma J, Rosenberg PS, Siegel R, Anderson WF. Increasing lung cancer death rates among young women in southern and midwestern states. J Clin Oncol. 2012;30:2739-2744.
29. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544-573.
30. Cress RD, Morris C, Ellison GL, Goodman MT. Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992-2001. Cancer. 2006;107(suppl 5):1142-1152.
31. Siegel RL, Ward EM, Jemal A. Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev. 2012;21:411-416.
32. Centers for Disease Control and Prevention, National Center for Health Statistics. National Health Interview Surveys, 2000 and 2015. Public use data files, 2001, 2016.
33. Morris LG, Tuttle RM, Davies L. Changing trends in the incidence of thyroid cancer in the United States. JAMA Otolaryngol Head Neck Surg. 2016;142:709-711.
34. Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016;2:1023-1029.
35. Zeng C, Wen W, Morgans AK, Pao W, Shu XO, Zheng W. Disparities by race, age, and sex in the improvement of survival for major cancers: results from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010. JAMA Oncol. 2015;1:88-96.
36. Sasaki K, Strom SS, O'Brien S, et al. Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials. Lancet Haematol. 2015;2:e186-e193.
37. Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR. 2016 US lymphoid malignancy statistics by World Health Organization subtypes [published online ahead of print September 12, 2016]. CA Cancer J Clin. doi: 10.3322/caac.21357.
38. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395-409.
39. Marcus PM, Doria-Rose VP, Gareen IF, et al. Did death certificates and a death review process agree on lung cancer cause of death in the National Lung Screening Trial? Clin Trials. 2016;13:434-438.
40. Doria-Rose VP, White MC, Klabunde CN, et al. Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2012;21:1049-1059.
41. Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008;100:1672-1694.
42. Holford TR, Meza R, Warner KE, et al. Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. JAMA. 2014;311:164-171.
43. US Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
44. Lortet-Tieulent J, Sauer AG, Siegel RL, et al. State-level cancer mortality attributable to cigarette smoking in the United States. JAMA Intern Med. 2016; Published online October 24, 2016. doi:10.1001/jamainternmed.2016.6530.
45. Heron M, Anderson RN. Changes in the Leading Cause of Death: Recent Patterns in Heart Disease and Cancer Mortality. NCHS Data Brief No. 254. Hyattsville, MD: National Center for Health Statistics; 2016.
46. Siegel R, Naishadham D, Jemal A. Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin. 2012;62:283-298.
47. Torre LA, Sauer AM, Chen MS Jr, Kagawa-Singer M, Jemal A, Siegel RL. Cancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: converging incidence in males and females. CA Cancer J Clin. 2016;66:182-202.
48. Reagan-Steiner S, Yankey D, Jeyarajah J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years-United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64:784-792.
49. Wiren S, Haggstrom C, Ulmer H, et al. Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control. 2014;25:151-159.
50. Walter RB, Brasky TM, Buckley SA, Potter JD, White E. Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst. 2013;105:860-868.
51. O'Grady TJ, Gates MA, Boscoe FP. Thyroid cancer incidence attributable to overdiagnosis in the United States 1981-2011. Int J Cancer. 2015;137:2664-2673.
52. Aschebrook-Kilfoy B, Ward MH, Sabra MM, Devesa SS. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid. 2011;21:125-134.
53. Rahbari R, Zhang L, Kebebew E. Thyroid cancer gender disparity. Future Oncol. 2010;6:1771-1779.
54. Joosse A, de Vries E, Eckel R, et al; Munich Melanoma Group. Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Invest Dermatol. 2011;131:719-726.
55. Crocetti E, Fancelli L, Manneschi G, et al. Melanoma survival: sex does matter, but we do not know how. Eur J Cancer Prev. 2016;25:404-409.
56. Scoggins CR, Ross MI, Reintgen DS, et al; Sunbelt Melanoma Trial. Gender-related differences in outcome for melanoma patients. Ann Surg. 2006;243:693-698; discussion 698-700.
57. Joosse A, Collette S, Suciu S, et al. Sex is an independent prognostic indicator for survival and relapse/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European Organisation for Research and Treatment of Cancer randomized controlled trials. J Clin Oncol. 2013;31:2337-2346.
58. Cymerman RM, Shao Y, Wang K, et al. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival. J Natl Cancer Inst. 2016;108.
59. Jemal A, Center MM, Ward E. The convergence of lung cancer rates between blacks and whites under the age of 40, United States. Cancer Epidemiol Biomarkers Prev. 2009;18:3349-3352.
60. Anderson C, Burns DM. Patterns of adolescent smoking initiation rates by ethnicity and sex. Tob Control. 2000;9(suppl 2):II4-II8.
61. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78-93.
62. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287:2106-2113.
63. Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008;58:9-31.
64. Barnett J, Vornovitsky M. Health Insurance Coverage in the United States: 2015. Current Population Reports P60-257. Washington, DC: US Census Bureau; 2016.
65. DeNavas-Walt C, Proctor B, Smith J. Income, Poverty, and Health Insurance Coverage in the United States: 2010. Current Population Reports P60-239. Washington, DC: US Census Bureau; 2011.
66. Welzel TM, Graubard BI, Quraishi S, et al. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol. 2013;108:1314-1321.
67. White MC, Espey DK, Swan J, Wiggins CL, Eheman C, Kaur JS. Disparities in cancer mortality and incidence among American Indians and Alaska Natives in the United States. Am J Public Health. 2014;104(suppl 3):S377-S387.
68. Ezzati M, Friedman AB, Kulkarni SC, Murray CJ. The reversal of fortunes: trends in county mortality and cross-county mortality disparities in the United States. PLoS Med. 2008;5:e66.
69. Grauman DJ, Tarone RE, Devesa SS, Fraumeni JF Jr. Alternate ranging methods for cancer mortality maps. J Natl Cancer Inst. 2000;92:534-543.
70. Nguyen BT, Han X, Jemal A, Drope J. Diet quality, risk factors and access to care among low-income uninsured American adults in states expanding Medicaid vs. states not expanding under the Affordable Care Act. Prev Med. 2016;91:169-171.